-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Neutral on United Therapeutics, Lowers Price Target to $315

Benzinga·06/11/2025 18:10:52
Listen to the news
B of A Securities analyst Greg Harrison maintains United Therapeutics (NASDAQ:UTHR) with a Neutral and lowers the price target from $321 to $315.